Medical Developments International LimitedASX: MVP

Interim CEO Remuneration Update

· Issued by Medical Developments International Limited via ASX

Filed with ASX · · 1 page · English

Summary by 6ix AI

Medical Developments International Limited has announced an update regarding the remuneration of its Interim CEO, Anita James, who also serves as Chief Financial Officer. The revised remuneration arrangements include an increase in total fixed remuneration while maintaining existing incentive percentages. The notice period for termination has been extended from three months to six months. Additionally, retention payments have been scheduled for the following year.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

18 November 2026 ASX ANNOUNCEMENT Interim CEO Remuneration Update Medical Developments International (ASX: MVP) refers to its announcement dated 15 October 2026 and the appointment of Anita James as Interim Chief Executive Officer in addition to her role as Chief Financial Officer. MVP today...

Medical Developments International Limited on 6ix

Earlier from Medical Developments International

Later from Medical Developments International

All Medical Developments International news releases